Abingworth as of Dec. 31, 2016
Portfolio Holdings for Abingworth
Abingworth holds 17 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Crispr Therapeutics (CRSP) | 43.7 | $52M | 2.6M | 20.00 | |
Paratek Pharmaceuticals | 16.8 | $20M | 1.3M | 15.35 | |
Sientra | 15.7 | $19M | 2.2M | 8.50 | |
Novan | 4.5 | $5.4M | 200k | 26.88 | |
Chiasma | 3.3 | $4.0M | 2.1M | 1.90 | |
Proteon Therapeutics | 3.0 | $3.6M | 2.0M | 1.80 | |
Cymabay Therapeutics | 2.3 | $2.7M | 1.6M | 1.70 | |
Dermira | 1.8 | $2.1M | 70k | 30.31 | |
Lombard Med (EVARF) | 1.7 | $2.0M | 3.5M | 0.59 | |
Cellectis S A (CLLS) | 1.4 | $1.7M | 100k | 16.91 | |
Histogenics Corp Cmn | 1.2 | $1.4M | 889k | 1.62 | |
Senseonics Hldgs (SENS) | 1.2 | $1.4M | 517k | 2.66 | |
Immune Design | 0.9 | $1.1M | 197k | 5.45 | |
Adaptimmune Therapeutics (ADAP) | 0.8 | $1.0M | 250k | 4.01 | |
Dicerna Pharmaceuticals | 0.8 | $973k | 338k | 2.88 | |
Anthera Pharmaceutcls | 0.5 | $560k | 862k | 0.65 | |
Innocoll | 0.3 | $360k | 537k | 0.67 |